edoxaban
Showing 26 - 50 of 56
Atrial Fibrillation Trial in Warren (Edoxaban, Warfarin)
Terminated
- Atrial Fibrillation
- Edoxaban
- Warfarin
-
Warren, New JerseyElectrophysiology Research Foundation
Jun 17, 2020
Non-Vitamin K Oral Anticoagulants in Older Atrial Fibrillation
Active, not recruiting
- Atrial Fibrillation
- +3 more
- Warfarin
- +4 more
-
Boston, MassachusettsBrigham and Women's Hospital
May 5, 2021
Intracranial Hemorrhages, Atrial Fibrillation Trial in Worldwide (Edoxaban, Non-anticoagulant medical therapy)
Recruiting
- Intracranial Hemorrhages
- Atrial Fibrillation
- Edoxaban
- Non-anticoagulant medical therapy
-
Elk Grove Village, Illinois
- +152 more
Jan 23, 2023
Edoxaban Treatment for Non-valvular Atrial Fibrillation in China
Recruiting
- Non-valvular Atrial Fibrillation
- Edoxaban
-
Beijing, Changping District, China
- +104 more
Jul 6, 2022
Thromboembolism, Cancer Trial in Italy (Edoxaban)
Unknown status
- Thromboembolism
- Cancer
- Edoxaban
-
Alessandria, Italy
- +17 more
Jul 29, 2020
Anticoagulant-induced Bleeding Trial in Quebec (Warfarin, Dabigatran, Rivaroxaban)
Not yet recruiting
- Anticoagulant-induced Bleeding
- Warfarin
- +4 more
-
Quebec, CanadaInstitut Universitaire de Cardiologie et de Pneumologie de Quebe
Feb 17, 2021
Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral
Completed
- Atrial Fibrillation
- Phenprocoumon
- +3 more
-
Multiple Locations, GermanyMany Locations
Nov 24, 2020
Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)
Completed
- Venous Thromboembolism (VTE)
- +2 more
- Edoxaban
- Standard of Care
-
Tucson, Arizona
- +139 more
Jun 28, 2022
Routine Clinical Practice for Atrial Fibrillation in Korea and
Completed
- Atrial Fibrillation
- Edoxaban
-
Cheonan, Chungcheongnam-do, Korea, Republic of
- +46 more
Jan 11, 2021
MV(Mitral Valve) Repair Trial in Seoul (Edoxaban, Warfarin, parenteral anti-coagulant (UFH))
Completed
- MV(Mitral Valve) Repair
- Edoxaban
- +2 more
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Dec 27, 2019
Variability of Whole Blood Clotting Time Measurements in Ex Vivo
Completed
- Healthy
- Blood drawn by direct venipuncture
- +3 more
- (no location specified)
May 19, 2020
Routine Clinical Practice for Non Valvular Atrial Fibrillation
Completed
- Atrial Fibrillation
- Edoxaban
-
Altenmarkt, Austria
- +723 more
May 26, 2022
Routine Clinical Practice in Venous Thromboembolism in Korea and
Completed
- Venous Thromboembolism
- Edoxaban
-
Gyeongsang, Gumi, Korea, Republic of
- +18 more
Dec 19, 2019
Atrial Fibrillation Trial in Germany (CE-mark approved LAA closure devices, Acetylsalicylic acid, Clopidogrel)
Recruiting
- Atrial Fibrillation
- CE-mark approved LAA closure devices
- +8 more
-
Berlin, Germany
- +25 more
Jul 29, 2021
Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,
Completed
- Intracranial Hemorrhages
- +8 more
- Apixaban
- +6 more
-
Edinburgh, Midlothian, United Kingdom
- +66 more
Mar 31, 2022
Medical Need of OAC Reversal
Completed
- Atrial Fibrillation
- warfarin
- +4 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Oct 31, 2018
Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) Trial in Worldwide (Edoxaban, Dalteparin, Low
Completed
- Venous Thromboembolism (VTE)
- +3 more
- Edoxaban
- +2 more
-
Brandon, Florida
- +8 more
Feb 8, 2019
Peripheral Arterial Disease Trial in Worldwide (edoxaban, Clopidogrel, Aspirin)
Completed
- Peripheral Arterial Disease
- edoxaban
- +2 more
-
Birmingham, Alabama
- +41 more
Feb 8, 2019
Atrial Fibrillation Trial in Worldwide (Edoxaban, VKA-Based Regimen)
Completed
- Atrial Fibrillation
- Edoxaban
- VKA-Based Regimen
-
Antwerpen, Belgium
- +74 more
Aug 26, 2019
Prevention, Venous Thromboembolism Trial in Osaka, Tokyo (edoxaban, enoxaparin sodium)
Completed
- Prevention
- Venous Thromboembolism
- edoxaban
- enoxaparin sodium
-
Osaka, Japan
- +1 more
Feb 8, 2019
Venous Thromboembolism Trial in Osaka, Tokyo, Kaohsiung (edoxaban, enoxaparin sodium)
Completed
- Venous Thromboembolism
- edoxaban
- enoxaparin sodium
-
Osaka, Japan
- +2 more
Feb 8, 2019